Definium Therapeutics, Inc. (DFTX) short interest & options flow
NASDAQDefinium Therapeutics enters the back half of August with a curious split: the Street is racing to lift price targets after positive Phase III data, yet the stock has shed 13% over the past month and shorts remain dug in at a meaningful 10.8% of float. The analyst picture is the most active part of the story right now. Targets have been moving sharply upward across the board…
DFTX short interest plummets 26% in one day to 10.8% of float, down from 14.4% on July 23rd, as stock rallies on analyst upgrades.
- Market cap
- $4.47B
- Next earnings
- 9 Nov 2026
Key data as of 9 Nov 2026
Latest signals on DFTX
- Short Interest
DFTX short interest plummets 26% in one day to 10.8% of float, down from 14.4% on July 23rd, as stock rallies on analyst upgrades.
DFTX news and analysis
RSSNo long-form analysis yet for DFTX. Pulse alerts and the live data picture are available on ORTEX.
Open DFTX on ORTEX →Want the live picture for DFTX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DFTX — free to start on ORTEX.
Sign up for free →Open DFTX on ORTEX